(S)-Warfarin
- Generic Name
- (S)-Warfarin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H16O4
- CAS Number
- 5543-57-7
- Unique Ingredient Identifier
- HP31W7FNP4
- Background
Warfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways. S-warfarin is 2-5 times more potent than the R-isomer in producing an anticoagulant response.
- Associated Conditions
- -
- Associated Therapies
- -
Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-01-25
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 28
- Registration Number
- NCT01517399
- Locations
- 🇺🇸
START - South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States
An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Biogen
- Target Recruit Count
- 133
- Registration Number
- NCT01462318
- Locations
- 🇵🇱
Research Site, Krakow, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath